CLDX vs SRPT · rev $37.0K vs rev $1.13B
Celldex Therapeutics Inc (CLDX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CLDX currently screens at market cap $2.35B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CLDX and SRPT stock pages for the full models.
Not investment advice.